Document is current
Any future updates will be listed below
-
Authors
Bryant, Jessica A.
Vulić, Marin https://orcid.org/0009-0009-3497-6646
Walsh, Emily A.
Allen, Edward G. Jr
Beauchemin, Nicholas J.
Chafee, Meghan E.
Diao, Liyang https://orcid.org/0009-0001-4932-0916
Fenn, Kathrin
Ford, Kara A.
Hasson, Brooke R. https://orcid.org/0009-0000-2991-0567
Litcofsky, Kevin D.
Lombardo, Mary-Jane
Martinez, Asuncion
O’Brien, Edward J.
Straub, Timothy J. https://orcid.org/0000-0001-5009-0778
Sykes, Sean M.
Marshall, Lisa Faye
Winkler, Jonathan A.
McGovern, Barbara H.
Ford, Christopher B. https://orcid.org/0000-0002-4079-8673
Wortman, Jennifer R.
Henn, Matthew R. https://orcid.org/0000-0001-8734-5797
- License Information
-
More Information
Article History
Received: 18 September 2023
Accepted: 24 October 2025
First Online: 5 January 2026
Competing interests
: M.V., E.A.W., N.J.B., M.E.C., B.R.H., M.-J.L., S.M.S., J.A.W., L.F.M., C.B.F. and M.R.H. are employees and shareholders of Seres Therapeutics. J.A.B., E.G.A., K.A.F., L.D., K.D.L., K.F., A.M., E.J.O., T.J.S., B.H.M. and J.R.W. are former employees and shareholders of Seres Therapeutics.
